Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. It has a research collaboration agreement with Synlogic, Inc. for the discovery of a novel synthetic biotic for the treatment of inflammatory bowel disease (IBD). The company was founded in 1896 and is headquartered in Basel, Switzerland.

Roche Holding AG

Roche Vietnam

Roche Belgium & Luxembourg

LabLeaders

Genentech

Roche Germany

Roche Diagnostics France

Roche Argentina

Roche Diagnostics Australia

Roche LATAM

Roche France

Roche Hungary

Roche Diabetes Care France

Roche Austria

Fondation Roche

Roche CustomBiotech - North America

Roche Česká republika

Roche Costa Rica

Roche Bangladesh

Roche Diagnostics USA

Roche Ecuador

Roche Indonesia

Roche Uruguay

Roche Danmark

Roche Sweden

Roche Israel

Roche Perú

Roche Malaysia 

Roche Chile

Roche Diagnostics Pakistan

Roche Diagnostics Polska

Roche (Philippines) Inc.

Roche Polska

Roche in Norway

Roche Africa

Roche Diagnostics Asia Pacific

Roche Australia

Roche Tunisia

Roche Canada

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.

Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.

Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI).

For more information, please visit https://careers.roche.com

Read our community guidelines here: 
https://www.roche.com/some-guidelines.htm

#Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation

Flatiron Health

Affimed

C4 Therapeutics

SoftBank

Novartis

SCALE AI

Roche

At Roche, our dedication to advancing women's health is unwavering. The #MyStoryForChange initiative is a testament to this commitment, bringing to light the stories of over 630 women. These stories are driving forces behind our efforts to create a healthcare system that truly understands and addresses women's unique needs. Our commitment is steadfast and action-oriented, aiming for tangible change. Discover more about our dedication to women's health in our digital annual report. ➡️http://spkl.io/60454vhNt 
#WomensHealth #HealthEquity #XProject #TogetherForChange #RocheFinancialResults 

Join us in celebrating #WomenInScience today and every day!

Today, on the International Day of Women and Girls in Science, we celebrate the courageous women who inspire and lead in science. Their voices are crucial for advancing gender equality in healthcare, Research & Development, and beyond. 🔬

👩‍🔬 To achieve gender equity, and truly #InspireInclusion, all voices must be heard. Women’s perspectives and experiences must be included in shaping healthcare decisions, Research & Development, and in the workplace. As we approach International Women's Day 2024, together, we can forge a more inclusive world by elevating these voices and creating spaces to listen, share, and shape a more equitable future.

➡️ http://spkl.io/60464aWSe

#InspireInclusion #WomenInSTEM


In 2023 we saw cut-through on the AI driven changes ahead, also in healthcare. The workforce, demographic, and financial challenges of health systems also became clear. More than ever, we need the #EUPharmaLegislation to deliver modern regulation that meets the opportunities and risks of healthcare’s digital transformation. We reiterate and underscore our #SixBoldActions for Regulatory Reform in Europe. #HealthcareInnovation. 


“For me, work has been the best therapy ever.”

Join the conversation between SMA My Way Champion, Pia Lemmetty, and her coach Anna Kuusela, as they explore career choices, balancing professional growth with personal commitments, and the healing power of work.🌱

https://lnkd.in/dEkEK9-C


As the world evolves, Roche continues to respond to the changing healthcare needs globally. Our 2023 journey has been about innovation, collaboration, and a profound commitment to a healthier future. We focus on the long-term, leading in research and development to improve lives today and for generations. Our global network's diverse perspectives and dedication have been pivotal in advancing science and ensuring healthcare access for all. Together, we're breaking new ground, driven by our collective care and the belief that our work creates more time with the people we love. That’s what makes us Roche. Discover our 2023 story in our digital annual report. #RocheFinancialResults #HealthierFuture #InvestInHealth #AdvancingScience

➡️ http://spkl.io/60404vCAA


SIX:RO

Roche Holding AG

Last Close

305.00

26/07 15:30

Market Cap

195.30B

Beta: 0.18

Volume Today

46.12K

Avg: 98.34K

PE Ratio

17.80

PFCF: 13.97

Dividend Yield

3.89%

Payout:68.82%

Filings Not Available